Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / Cm Technologies, Inc.

Approvalsnovel device granted (FDA De Novo)20 Aug 2026

Cm Technologies, Inc.

20 Aug 2026: Novel device granted (FDA De Novo) · Qoramatic Automated Stool Management. Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
20 Aug 2026
Device
Qoramatic Automated Stool Management
Specialty
Gastroenterology, Urology
Product Code
SJB
Country
United States
Location
Carrollton, TX
Submitted
2025-09-15
Reference
DEN250043
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at Cm Technologies, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Cm Technologies, Inc. in our registers.

More in Gastroenterology, Urology

De Novo Grants

See all

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.